Legis Daily

Federal Kratom Consumer Protection Act

USA118th CongressS-3039| Senate 
| Updated: 10/4/2023
Mike Lee

Mike Lee

Republican Senator

Utah

Cosponsors (1)
Cory A. Booker (Democratic)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Federal Kratom Consumer Protection Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 4, 2023
Introduced in Senate
Oct 4, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Oct 25, 2023

Latest Companion Bill Action

HR 118-5905
Referred to the House Committee on Energy and Commerce.
  • October 4, 2023
    Introduced in Senate


  • October 4, 2023
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


  • October 25, 2023

    Latest Companion Bill Action

    HR 118-5905
    Referred to the House Committee on Energy and Commerce.

Health

Related Bills

  • HR 118-5905: Federal Kratom Consumer Protection Act
Administrative law and regulatory proceduresAdvisory bodiesCongressional oversightConsumer affairsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFood and Drug Administration (FDA)Food supply, safety, and labelingGovernment information and archivesResearch administration and funding

Federal Kratom Consumer Protection Act

USA118th CongressS-3039| Senate 
| Updated: 10/4/2023
Federal Kratom Consumer Protection Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 4, 2023
Introduced in Senate
Oct 4, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Oct 25, 2023

Latest Companion Bill Action

HR 118-5905
Referred to the House Committee on Energy and Commerce.
  • October 4, 2023
    Introduced in Senate


  • October 4, 2023
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


  • October 25, 2023

    Latest Companion Bill Action

    HR 118-5905
    Referred to the House Committee on Energy and Commerce.
Mike Lee

Mike Lee

Republican Senator

Utah

Cosponsors (1)
Cory A. Booker (Democratic)

Health, Education, Labor, and Pensions Committee

Health

Related Bills

  • HR 118-5905: Federal Kratom Consumer Protection Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAdvisory bodiesCongressional oversightConsumer affairsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFood and Drug Administration (FDA)Food supply, safety, and labelingGovernment information and archivesResearch administration and funding